Pharmaceutical Online Published Freyr’s Perspective on Quality Imperatives in OSD Manufacturing

Manufacturing oral solid dosage (OSD) forms is intricate, requiring strict adherence to Regulatory standards, efficient workflow management, and robust quality control measures. Would you like to gain insights into critical aspects of OSD manufacturing and understand Regulatory guidelines within the context of quality? What do you think are the key considerations for manufacturing, emphasizing the need for a clear description of the process and technical justifications for any changes?

NUFFOODS Spectrum Published Fryer’s Regulatory Insights on Functional Foods in Japan

Japan's robust functional food market, shaped by Regulatory frameworks like Foods with Function Claims (FFC) and Foods for Specified Health Use (FOSHU), offers a solid backdrop for innovation and growth. With over 7,000 FFC products registered, Japan presents lucrative opportunities for health and wellness companies and food manufacturers seeking to tap into the health-conscious Japanese consumer base.

Fifteen (15) FAQs on Unlocking the Drug Approval Process in Colombia

The Colombian healthcare system prioritizes patient safety and access to effective medications. To achieve these objectives, the National Institute of Drug and Food Surveillance (INVIMA) acts as the central Regulatory authority overseeing the approval process for pharmaceuticals.

This blog serves as your guide, unlocking fifteen (15) most Frequently Asked Questions (FAQs) on the drug approval process in Colombia.

What is the CPAC in South Korea?

The Central Pharmaceutical Affairs Council (CPAC) plays a vital role in ensuring the safety and efficacy of drugs marketed in South Korea. Established under the Pharmaceutical Affairs Act (PAA), this high-level government advisory body functions as the gatekeeper for new medications entering the market.

The Drug Approval Process

The CPAC’s core function lies in reviewing and approving new drugs for sale in South Korea. This rigorous process involves meticulous evaluation of scientific evidence, based on factors such as:

RAPS Regulatory Intelligence Conference

We are thrilled to announce that Freyr GRI will be sponsoring the RAPS Regulatory Intelligence Conference from 6th - 7th June, 2024, in Baltimore, USA.

As a leader in Regulatory intelligence domain, we are committed to staying at the forefront of innovation and industry developments and the upcoming RAPS Regulatory Intelligence Conference gives us the perfect opportunity to showcase our commitment. 

Demystifying eCTD Submissions for Seamless Interactions with Health Authorities

The global pharmaceutical market is expected to reach a staggering $1.5 trillion by 2025, fuelled by continuous innovation and a growing demand for life-saving treatments. The electronic Common Technical Document (eCTD) submission process plays a pivotal role in achieving this goal.

Common types of Regulatory Submissions

Regulatory submissions are essential in the pharmaceutical and biotech sectors as they play a key role in introducing new therapies to the market and maintaining compliance.   Companies in the United States (US) and the European Union (EU) must have a thorough understanding of the different types of submissions mandated by Regulatory authorities.   These submissions, ranging from clinical trial applications to post-approval commitments, serve distinct purposes in the process of drug development and approval.    The purpose of this blog post is to offer a thorough examination of the typical